Company Performance Metrics
Gil Lotan: Vice President of Business DevelopmentPast Role: Spacecom, General Counsel- Almog Aley-Raz: Co-Founder, CEO, and VP R&D
CorNeat Vision is a clinical-stage, biomimetic implants and technology company. Our patented, nondegradable, synthetic, platform material - The CorNeat EverMatrix™ - is set to displace harvested and processed human and animal tissues, and degradable Extra Cellular Matrices (ECMs), the protein skeleton of the tissue, used in a variety of surgical
procedures across diversified fields of medicine.
The CorNeat EverMatrix™ addresses the main issue with implants and implantables – the foreign body response they trigger leading either to their degradation and absorbance, or encapsulation. The CorNeat EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants that can:
• Bio-mechanically integrate with surrounding tissue • Permanently reinforce soft tissue and accelerate its healing • Act as a membrane for guided soft tissue and bone regeneration • Conceal irritating implants • Enable sensors to continuously remain in contact with surrounding tissue
The features and benefits of the CorNeat EverMatrix™ were proven histologically and clinically in over a dozen in-vitro and in-vivo studies, including in humans.
